Perifosine plus lenalidomide and dexamethasone in relapsed and relapsed/refractory multiple myeloma: a Phase I Multiple Myeloma Research Consortium study (Q33401457)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Perifosine plus lenalidomide and dexamethasone in relapsed and relapsed/refractory multiple myeloma: a Phase I Multiple Myeloma Research Consortium study	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Perifosine plus lenalidomide and dexamethasone in relapsed and relapsed/refractory multiple myeloma: a Phase I Multiple Myeloma Research Consortium study (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

based on heuristic

inferred from title

multiple myeloma

1 reference

based on heuristic

inferred from title

Kenneth C. Anderson

15

object named as

Kenneth C Anderson

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Paul G. Richardson

2

object named as

Paul G Richardson

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Peter Sportelli

11

object named as

Peter Sportelli

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

10

object named as

Teru Hideshima

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

4

object named as

Melissa Alsina

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Colleen K Harvey

9

object named as

Colleen Harvey

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Enrique Poradosu

12

object named as

Enrique Poradosu

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

13

object named as

Lesa Gardner

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Jonathan L Kaufman

5

object named as

Jonathan L Kaufman

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Andrzej Jakubowiak

1

object named as

Andrzej J Jakubowiak

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Todd Zimmerman

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Malathi Kandarpa

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Stephanie Kraftson

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Charles W Ross

8

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Kathy Giusti

14

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

29 May 2012

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

158

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

472-480

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09173.X

21 January 2018

Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09173.X

21 January 2018

International uniform response criteria for multiple myeloma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09173.X

21 January 2018

Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09173.X

21 January 2018

Advances in biology of multiple myeloma: clinical applications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09173.X

21 January 2018

Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09173.X

21 January 2018

Lenalidomide, adriamycin, and dexamethasone (RAD) in patients with relapsed and refractory multiple myeloma: a report from the German Myeloma Study Group DSMM (Deutsche Studiengruppe Multiples Myelom).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09173.X

21 January 2018

Bortezomib in combination with intermediate-dose dexamethasone and continuous low-dose oral cyclophosphamide for relapsed multiple myeloma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09173.X

21 January 2018

Improved survival in multiple myeloma and the impact of novel therapies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09173.X

21 January 2018

The use of novel agents in the treatment of relapsed and refractory multiple myeloma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09173.X

21 January 2018

Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09173.X

21 January 2018

Bortezomib, doxorubicin and dexamethasone in advanced multiple myeloma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09173.X

21 January 2018

Combination of the mTOR inhibitor rapamycin and CC-5013 has synergistic activity in multiple myeloma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09173.X

21 January 2018

Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09173.X

21 January 2018

Bortezomib or high-dose dexamethasone for relapsed multiple myeloma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09173.X

21 January 2018

New drugs for myeloma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09173.X

21 January 2018

Perifosine plus bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma previously treated with bortezomib: results of a multicenter phase I/II trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09173.X

21 January 2018

The addition of cyclophosphamide to lenalidomide and dexamethasone in multiply relapsed/refractory myeloma patients; a phase I/II study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09173.X

21 January 2018

Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by up-regulating the insulin-like growth factor receptor/insulin receptor substrate-1/phosphatidylinositol 3-kinase cascade.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09173.X

21 January 2018

Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09173.X

21 January 2018

Combined functional and molecular analysis of tumor cell signaling defines 2 distinct myeloma subgroups: Akt-dependent and Akt-independent multiple myeloma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2012.09173.X

21 January 2018

Identifiers

10.1111/J.1365-2141.2012.09173.X

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33401457&oldid=1903861816"